Stock listing
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A
Selected listing: 9989 · HKEX · HKD · HK
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (HKEX:9989), Health Technology. Latest release May 11, 2026: Resverlogix Announces One-Year Extension…
- Ticker
- HKEX:9989
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- HKEX
- Currency
- HKD
Latest news from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A
Resverlogix Announces One-Year Extension of Debenture
May 11, 2026
Shenzhen Hepalink Pharmaceutical : RESIGNATION OF VICE CHAIRMAN AND EXECUTIVE DIRECTOR
May 6, 2021
Shenzhen Hepalink Pharmaceutical : VOLUNTARY ANNOUNCEMENT"HEPTRIS" OBTAINS APPROVAL FROM BRAZILIAN HEALTH REGULATORY AGENCY
April 21, 2021
Shenzhen Hepalink Pharmaceutical : (1) RESIGNATION OF NON-EXECUTIVE DIRECTOR (2) PROPOSED APPOINTMENT OF EXECUTIVE DIRECTOR
April 20, 2021
Shenzhen Hepalink Pharmaceutical : VOLUNTARY ANNOUNCEMENT - "INHIXA" OBTAINS APPROVAL FROM NORTH MACEDONIA
April 13, 2021
All Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A news →
Research Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A company profile
View the public company page for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A on 6ix.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A news
Read company news and market updates connected to Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A investor events
Find investor webinars, events, and replay context for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A.